Business Wire

JEOL: ECZ Luminous, a Brand-new High-resolution Nuclear Magnetic Resonance System, Is Now Available

1.11.2021 12:00:00 EET | Business Wire | Press release

Share

JEOL Ltd. (TOKYO:6951)(President & COO Izumi Oi) announced the "ECZ Luminous" nuclear magnetic resonance console (JNM-ECZL series) on November 1, 2021.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211101005380/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

JNM-ECZL R series (Photo: Business Wire)

This product is a next step in spectrometer miniaturization and extended performance through state-of-the-art digital and high-frequency technologies.

Main Features

  1. The Highest Performance in the World's Smallest Chassis
    The ECZL chassis world's smallest chassis, while offering high performance for liquids as well as solid-state NMR. The latest NMR spectrometer features a high degree of configuration flexibility and contributes to cutting-edge research in a variety of situations.
  2. Stable, Fast, and Highly-sensitive
    All circuits have been converted to digital versions. The STS (Smart Transceiver System), inherited from the previous model, achieves a time resolution of 5 ns for frequency, phase and amplitude modulation, enabling ultra-fast control.
  3. Multiple Resonance Experiments
    The MFDS (Multi Frequency Drive System) enables multiple simultaneous pulse trains on different nuclei on a single RF channel.
  4. Remote Access and Automation
    The ECZL can be remotely accessed from any computer on the network so that multiple operators can access the spectrometer simultaneously without interfering with each other's operations. Combined with an automatic sample changer, the ECZ Luminous system can be used remotely in continuous automation for both solution and solid-state NMR measurements.

ECZ Luminous Lineup

  1. ECZL G series (400 MHz to 1.3 GHz)
    ECZL G series is the flagship model and supports expansion to more than 3 channels, high power amplifiers, and high magnetic field gradients. The footprint has been reduced to about half that of the previous model, while offering various expansion capabilities.
  2. ECZL R series (400 to 600 MHz)
    ECZL R series is a high-performance instrument equipped with a power amplifier capable of solid-state NMR measurements, and is the world's smallest, with less than half the footprint and only one-third the volume of previous models.
  3. ECZL S series (400 MHz)
    The ECZL S series is an entry-level model with exactly the same architecture as the high-end models, specializing in 400 MHz solution measurements at a reduced price.

Sales target
250 units/year

Product URL: https://www.jeol.co.jp/en/products/detail/JNM-ECZL.html

JEOL Ltd.
3-1-2, Musashino, Akishima, Tokyo, 196-8558, Japan
Izumi Oi, President & COO
(Stock code: 6951, Tokyo Stock Exchange First Section)
www.jeol.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

JEOL Ltd.
Science and Measurement Instruments Sales Division
Katsuo ASAKURA
TEL: +81-3-6262-3575
E-mail: kasakura@jeol.co.jp
https://www.jeol.co.jp/en/support/support_system/contact_products.html

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth19.5.2026 09:00:00 EEST | Press release

ATB Therapeutics (“ATB” or the “Company”), a biopharmaceutical company advancing next-generation antibody-based therapies for oncology and immunology, today announced the appointment of Mark Throsby, PhD, as Chief Executive Officer. The leadership transition marks an important milestone as the Company continues its evolution from a startup into a development-stage biopharmaceutical company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260513198633/en/ ATB Therapeutics Appoints Mark Throsby as CEO to Lead Next Phase of Growth Mark Throsby has served as Executive Chairman and Chief Scientific Officer since 2024, during which time he supported the Company’s growth, including the successful closing of its Series A financing, the expansion of the scientific team, and the advancement of its therapeutic programs. In his new role, he will lead ATB’s strategy and senior leadership team as the Company prepares to enter clinical deve

TREASoURcE Shows How Circular Economy Solutions Can Move Beyond Pilots Across Sectors and Regions19.5.2026 08:00:00 EEST | Press release

Across Europe, many circular economy solutions struggle to move beyond isolated pilots and into real-world deployment at scale. New approaches are needed that combine technical feasibility, market relevance and citizen engagement, while remaining adaptable to local contexts. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260518914041/en/ TREASoURcE addressed circular economy challenges across energy, plastics and biobased side streams, combining technical solutions with stakeholder and citizen engagement. The EU-funded TREASoURcE project provides evidence that systemic, citizen-engaged circular economy solutions can be developed, tested and prepared for replication across regions. Using a common regional approach, the project combined real-life demonstrations, cross-value chain collaboration and early consideration of transferability to translate circular economy concepts into practical solutions in the fields of energy, mat

Shufti Recognised as Dual Leader in Liminal's 2026 Age Verification and Age Estimation Indexes, with Exceptional Ratings Across Both Benchmarks19.5.2026 08:00:00 EEST | Press release

Shufti has been named a Leader in both the Age Verification and Age Estimation categories of Liminal’s 2026 Index Report, receiving an Exceptional rating for Market Presence across both. Liminal, an actionable intelligence firm, evaluates identity verification vendors across Product Execution, Strategy, and Market Presence, assessing scalability, accuracy, fraud resistance, innovation, and user experience. Out of 189 vendors assessed in the Age Verification Index, only 17 achieved Leader status. Shufti was among them and exceeded the leadership threshold with a 64% Product Execution score and a 92% Strategy score. In Age Estimation, Shufti again ranked among 17 Leaders from 80 evaluated vendors, exceeding leadership thresholds across core evaluation pillars, alongside an Exceptional Market Presence rating in both categories. “Achieving Leader status in both Age Estimation and Age Verification reflects that our solutions are built for accurate, scalable, and privacy-first age assurance

Azafaros Strengthens Leadership Team With Appointment of Amy Sullivan as Chief Financial Officer19.5.2026 08:00:00 EEST | Press release

Azafaros, a private company building a portfolio to become a leader in Lysosomal Storage Disorders and focused on addressing neurological symptoms, today announced that Amy Sullivan has joined the company as Chief Financial Officer. Ms. Sullivan brings more than 30 years’ experience in the life sciences sector, with expertise in capital raising, corporate strategy and communications. She joins Azafaros from IO Biotech, where she served as Chief Financial Officer. “Amy is a highly accomplished financial leader with a strong track record of supporting growth-stage biotech companies,” said Stefano Portolano, Chief Executive Officer at Azafaros. “Her expertise in financing, strategic positioning and transaction execution will be instrumental as we advance our Phase 3 studies with nizubaglustat and continue to build Azafaros as we prepare to file for drug marketing authorization and launch in GM1/GM2 and NPC.” “I am excited to join Azafaros at such an important stage in the company’s develo

Tennis World Champion Carlos Alcaraz Becomes Global Brand Ambassador for Ant International19.5.2026 06:10:00 EEST | Press release

Global tennis icon Carlos Alcaraz has become the new Global Brand Ambassador for Ant International, a leading global digital payment, digitisation and financial technology provider, and its key brands. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260518952984/en/ (L-R) Ant International CEO Peng Yang and Carlos Alcaraz celebrate Global Brand Ambassador partnership This collaboration underscores Ant International’s commitment to enabling inclusive growth across global markets through a relentless pursuit of world-leading AI-powered payment and fintech solutions for businesses and individuals – a vision that mirrors the fierce energy and inspiration Carlos Alcaraz brings to every match. “Carlos is not only a sporting champion, but the very personification of the core values of tennis for fans worldwide: boundless ambition, unwavering dedication, scalpel precision in delivery, and sportsmanship both on and off the court,” sai

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye